View PDF
|
|
Cover |
|
Commentary |
|
A. Antiretroviral Medications |
Table 1 |
HIV-infected patients ever prescribed antiretroviral therapy by data source and sex |
Table 2 |
HIV-infected patients ever prescribed antiretroviral therapy by data source and race/ethnicity |
Table 3 |
HIV-infected patients currently prescribed antiretroviral therapy by data source and insurance status |
Table 4 |
HIV-infected patients currently prescribed antiretroviral therapy by data source and sex |
Table 5 |
HIV-infected patients currently prescribed antiretroviral therapy by data source and race/ethnicity |
Table 6 |
HIV-infected patients currently prescribed highly active antiretroviral therapy (HAART) by data source and insurance status |
Table 7 | HIV-infected patients currently prescribed highly active antiretroviral therapy (HAART) by data source and sex |
Table 8 | HIV-infected patients currently prescribed highly active antiretroviral therapy (HAART) by data source and race/ethnicity |
| |
B. Pneumocystis carinii
Pneumonia |
Table 9 |
HIV-infected patients ever diagnosed with Pneumocystis carinii
pneumonia (PCP) by data source and sex |
Table 10 |
HIV-infected patients ever diagnosed with Pneumocystis carinii
pneumonia (PCP) by data source and race/ethnicity |
Table 11 |
HIV-infected patients currently prescribed Pneumocystis carinii
pneumonia (PCP) prophylaxis by data source and insurance status |
Table 12 |
HIV-infected patients prescribed primary Pneumocystis carinii
pneumonia (PCP) prophylaxis by data source and sex |
Table 13 |
HIV-infected patients prescribed primary Pneumocystis carinii
pneumonia (PCP) prophylaxis by data source and race/ethnicity |
| |
C. Tuberculin Skin Test |
Table 14 |
HIV-infected patients receiving a tuberculin skin test (TST) by data source and sex |
Table 15 |
HIV-infected patients receiving a tuberculin skin test (TST) by data source and race/ethnicity |
|
Technical
Notes |